Medclair AB (NGM:MCLR)
Sweden
· Delayed Price · Currency is SEK 2.690
-0.070 (-2.54%)
At close: Dec 2, 2025
Medclair AB Income Statement
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Revenue | 50.04 | 35.95 | 42.42 | 28.17 | 13.32 | 6.41 | Upgrade
|
| Revenue Growth (YoY) | -0.53% | -15.25% | 50.60% | 111.49% | 107.70% | 10.30% | Upgrade
|
| Cost of Revenue | 14.25 | 12.6 | 17.66 | 7.76 | 5.8 | 2.15 | Upgrade
|
| Gross Profit | 35.79 | 23.35 | 24.76 | 20.41 | 7.52 | 4.26 | Upgrade
|
| Selling, General & Admin | 24.66 | 24.31 | 21.91 | 19 | 15.32 | 5.36 | Upgrade
|
| Other Operating Expenses | 0.23 | -0.08 | -0.05 | - | -0.09 | -0.45 | Upgrade
|
| Operating Expenses | 29.94 | 29.51 | 27.39 | 24.38 | 20.34 | 5.95 | Upgrade
|
| Operating Income | 5.85 | -6.17 | -2.63 | -3.97 | -12.82 | -1.69 | Upgrade
|
| Interest Expense | -5.86 | -0.23 | -0.37 | -0.08 | -0.11 | -0.11 | Upgrade
|
| Interest & Investment Income | - | 0.19 | 0.2 | - | - | - | Upgrade
|
| Currency Exchange Gain (Loss) | -0.57 | -0.57 | -0.83 | -0.37 | -0.09 | - | Upgrade
|
| Other Non Operating Income (Expenses) | -0.3 | - | -0 | - | - | - | Upgrade
|
| EBT Excluding Unusual Items | -0.88 | -6.76 | -3.63 | -4.42 | -13.01 | -1.81 | Upgrade
|
| Gain (Loss) on Sale of Assets | 6.1 | 6.1 | 0.85 | -0.57 | - | - | Upgrade
|
| Asset Writedown | - | - | - | - | - | -0.2 | Upgrade
|
| Pretax Income | 5.22 | -0.66 | -2.78 | -4.99 | -13.01 | -2.01 | Upgrade
|
| Income Tax Expense | - | - | 0.01 | 0.01 | 0.01 | - | Upgrade
|
| Net Income | 5.22 | -0.66 | -2.79 | -5 | -13.02 | -2.01 | Upgrade
|
| Net Income to Common | 5.22 | -0.66 | -2.79 | -5 | -13.02 | -2.01 | Upgrade
|
| Shares Outstanding (Basic) | 77 | 66 | 93 | 83 | 81 | - | Upgrade
|
| Shares Outstanding (Diluted) | 77 | 66 | 93 | 83 | 81 | - | Upgrade
|
| Shares Change (YoY) | -19.15% | -28.47% | 11.40% | 2.41% | - | - | Upgrade
|
| EPS (Basic) | 0.07 | -0.01 | -0.03 | -0.06 | -0.16 | - | Upgrade
|
| EPS (Diluted) | 0.07 | -0.01 | -0.03 | -0.06 | -0.16 | - | Upgrade
|
| Free Cash Flow | 3.58 | 1.19 | 4.23 | -11.77 | -8.68 | 0.18 | Upgrade
|
| Free Cash Flow Per Share | 0.05 | 0.02 | 0.05 | -0.14 | -0.11 | - | Upgrade
|
| Gross Margin | 71.53% | 64.94% | 58.38% | 72.46% | 56.45% | 66.42% | Upgrade
|
| Operating Margin | 11.69% | -17.16% | -6.20% | -14.09% | -96.25% | -26.40% | Upgrade
|
| Profit Margin | 10.43% | -1.85% | -6.57% | -17.75% | -97.76% | -31.33% | Upgrade
|
| Free Cash Flow Margin | 7.15% | 3.31% | 9.97% | -41.79% | -65.16% | 2.73% | Upgrade
|
| EBITDA | 10.3 | -1.49 | 1.88 | 0.12 | -8.85 | -0.86 | Upgrade
|
| EBITDA Margin | 20.58% | -4.16% | 4.44% | 0.41% | -66.44% | -13.38% | Upgrade
|
| D&A For EBITDA | 4.45 | 4.67 | 4.52 | 4.09 | 3.97 | 0.84 | Upgrade
|
| EBIT | 5.85 | -6.17 | -2.63 | -3.97 | -12.82 | -1.69 | Upgrade
|
| EBIT Margin | 11.69% | -17.16% | -6.20% | -14.09% | -96.25% | -26.40% | Upgrade
|
| Revenue as Reported | 36.71 | 36.71 | 43.32 | 28.44 | 13.41 | 6.9 | Upgrade
|
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.